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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S139expression in human chondrocytes. This in turn provides an important
and novel perspective for developing therapeutic strategies to treat
OA.268
IMPACT OF MECHANICAL LOADING OF OSTEOBLASTS ON
CHONDROCYTES: A NOVEL MURINE MODEL FOR ASSESSING BONE/
CARTILAGE COMMUNICATION
S. Priam 1, X. Houard 1, M. Gosset 1, C. Salvat 1, F. Berenbaum1,2,
C. Jacques 1. 1UR 4 - Univ. Pierre et Marie Curie, Paris, France;
2Rheumatology, AP-HP St-Antoine Hospital, France
Purpose: Osteoarthritis (OA) is characterized by joint degeneration,
leading to a progressive loss of articular cartilage in response to
mechanical and biochemical factors. However, OA is a complex disease
not limited to cartilage degeneration. Indeed, several sets of in vitro
and in vivo experiments suggest that subchondral bone remodeling
could initiate and/or contribute to cartilage loss in OA through a bone/
cartilage interplay. The aim of this study was to demonstrate the
ability of soluble mediators released by loaded osteoblasts to shift the
articular chondrocyte phenotype from a resting to a pro-degradative
phenotype through a novel and unique bone/cartilage communication
model.
Methods: Thanks to a three dimensional (3D) culture model, murine
calvaria osteoblasts were submitted to compression in Biopress Flexercell
plates (1.7 MPa, 1Htz during 24h). Then, media from loaded or unloaded
osteoblasts were used to treat primary mouse articular chondrocytes for
24h. Chondrocyte expression and secretion of matrix metalloproteinases
(MMP-3 and -13), MMPs inhibitors (TIMP-1, -2 and -3) and extracellular
matrix proteins (type II collagen, aggrecan) were analyzed by real time RT-
PCR, ELISA and immunoblotting. Osteoblast conditioned media were then
analyzed by iTRAQ (isobaric tags for relative and absolute quantiﬁcation),
a quantitative proteomic approach.
Results: Media from compressed osteoblast (CM) strongly induced
MMP-3 and -13 chondrocyte mRNA expression (Table). Consistently,
CM also signiﬁcantly stimulated the releases of MMP-3 and -13 by
chondrocytes (respectively 10.60.75 fold, p<0.001, and 6.52.1 fold,
p<0.01 compared to control). In addition, CM enhances TIMP-1
expression whereas it strongly inhibited TIMP-2 and -3 expressions
(Table). Osteoblast conditioned media also affected cartilage matrix
proteins expressions. Indeed, CM downregulated aggrecan and type II
collagen mRNA levels (Table). Effects of CM on cytosolic type II
collagen protein amounts were conﬁrmed by western blot (a decrease
of 319%, p<0.01).
Finally, in order to identify osteoblast soluble mediators responsible for
this chondrocyte phenotype, osteoblast conditioned media were
analyzed by iTRAQ. This advanced and sophisticated new
proteomic technique allowed identiﬁcation of 105 proteins secreted by
osteoblasts among which only 10% were modiﬁed in response to
compression.
Conclusions: These results support the hypothesis that soluble
mediators released by bone cells submitted to a mechanical stress
promote chondrocyte activation leading to the release of pro-degra-
dative mediators. Analysis of these soluble mediators will open a new
area of novel biomarkers relying on abnormal bone-cartilage
communication.Table
Effects of media from uncompressed (UCM) or compressed (CM) osteoblasts on MMPs
compared to control (non-stimulated chondrocytes).
MMP-3 MMP-13 TIMP-1 TIMP
UCM 5.93 (ns) 3.40.4 (ns) 1.50.4 (ns) 0.7
CM 50.914.5 (p<0.001) 18.310.9 (p<0.01) 5.21.6 (p<0.001) 0.5269
INHIBITION OF CYCLOOXYGENASE-2 IMPACTS CHONDROCYTE
HYPERTROPHY
M.J. Caron 1, P.J. Emans 1, M.P. Janssen 1, K. Sanen 1, M.M. Coolsen 1,
L. Voss 1, D.A. Surtel 1, A. Cremers 1, J.-W. Voncken 2, T.J. Welting 1,
L.W. van Rhijn 1. 1Dept. Orthopaedic Surgery, Maastricht Univ. Med. Ctr.,
Maastricht, Netherlands; 2Dept. Molecular Genetics, Maastricht Univ. Med.
Ctr., Maastricht, Netherlands
Purpose: Skeletogenesis and bone fracture healing involve endochondral
ossiﬁcation, a process during which cartilaginous primordia are gradually
replaced by bone tissue. In line with a role for cyclooxygenase-2 (COX-2) in
the endochondral ossiﬁcation process, non-steroidal anti-inﬂammatory
drugs (NSAIDs) were reported to negatively affect bone fracture healing
due to impaired osteogenesis. However, a role for COX-2 activity in the
chondrogenic phase of endochondral ossiﬁcation has not been addressed
before.
Methods: The role of COX-2 was studied during chondrogenic differenti-
ation of ATDC5 cells and rabbit periosteal explants. BMP-2 was used to
increase hypertrophic differentiation and the NSAIDs NS398 and Celecoxib
were applied to speciﬁcally inhibit COX-2 activity. Chondrogenic outcome
was measured by gene- and protein expression analysis, and (immuno)
histochemical stainings. For in vivo evidence skeletally immature NZW
rabbits were treated with Celecoxib (10mg/kg) for 21 days. Growth plate
development was analyzed by histochemistry.
Results: Our data reveal essential cross-talk between COX-2 and BMP-2
during chondrocyte hypertrophic differentiation. BMP-2 mediated chon-
drocyte hypertrophy is associated with increased COX-2 expression and
pharmacological inhibition of COX-2 activity decreased BMP-2 induced
hypertrophic differentiation in independent chondrogenic models in vitro
and ex vivo, while leaving chondrogenesis unaltered. Importantly,
systemic inhibition of COX-2 activity in vivo resulted in signiﬁcantly
decreased growth plate thickness, which could be attributed to impaired
chondrocyte hypertrophic differentiation.
Conclusions: Our ﬁndings demonstrate that COX-2 is an important
executing factor of BMP-2-induced chondrocyte hypertrophy in the
context of endochondral ossiﬁcation. These observations provide a novel
etiological perspective on the adverse effects of NSAIDs on bone fracture
healing and have important implications for the use of NSAIDs during
endochondral skeletal development. In addition, our data provides a novel
strategy to improve the outcome of cartilage regenerative medicine by
decreasing the level of unwanted chondrocyte hypertrophy and ossiﬁca-
tion.
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MIR-29B IS OVEREXPRESSED IN OSTEOARTHRITIC PATIENTS AND
TARGETS TYPE II COLLAGEN.
D. Moulin 1, V. Salone 1, M. Koufany 1, T. Clement 2, P. Netter 1, I. Behm-
Ansmant 2, B. Charpentier 2, C. Branlant 2, J.-Y. Jouzeau 1. 1 Laboratoire de
Physiopathologie et Pharmacologie Articulaires, Vandoeuvre les Nancy,
France; 2UMR 7214 AREMS, Vandoeuvre les Nancy, France
Purpose: MiRNAs are single strand non-coding small (21 to 24 nucle-
otides long) RNAs. They act as post-transcriptional repressors by
blocking translation or enhancing mRNA degradation. In osteoarthritis
cartilage, extracellular matrix synthesis by chondrocytes is disrupted.
This functional abnormality is associated to chondrocyte phenotype, TIMPs and matrix proteins chondrocytes expression. Results are expressed in fold
-2 TIMP-3 Collagen II Aggrecan
0.2 (p<0.01) 0.60.1 (p<0.001) 0.70.3 (ns) 0.70.3 (ns)
1.6 (p<0.001) 0.10.05 (p<0.001) 0.40.1 (p<0.01) 0.20.1(p<0.001)
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articular chondrocyte phenotype could be a consequence miRNAs
expression changes. Our objectives were: i) to identify alteration in
miRNAs pattern during osteoarthritis establishment or in a model of
phenotype chondrocytes loss (cytokine stress, subculturing).ii) to search
for their potential targets by in silico analysis; iii) to conﬁrm the func-
tional role of the miRNA candidate with the highest differential
expression.
Methods: A 1200 miRNAs pattern has been established by microRNA chip
analysis of human chondrocytes stimulated with IL-1beta or after sub-
culturing (P3). The expression of candidates miRNAs (selected after chip
analysis) was conﬁrmed by qRT-PCR and their potential targets identiﬁed
by in silico analysis using Microcosm, targetScan and Pictar tools. Amongst
miRNAs of interest, we focused on miR-29b, known to be a regulator of
collagen expression in other cell types. Then, we performed qRT-PCR
analysis of 18 osteoarthritic patients and 7 healthy age-matched donors.
The miR-29b potential seed region identiﬁed in the 3’UTR of type II
collagen was cloned directly upstream luciferase coding sequence and
under constitutive promoter control. Stable transfectants overexpressing
miR-29b were generated in ATDC5 chondrogenic cell line and collagen
synthesis was followed up during differentiation (Sirius red staining).
Finally, chondrocytes from 5 patients were transfected with miR-29b
overexpressing vector and type II collagen neosynthesis was determined
by C2CP ELISA.
Results: A subset of 20 miRNAs differentially expressed during
experimentally induced loss of chondrocyte phenotype was isolated.
Some of these miRNAs (miR-140, mir-455) were previously identiﬁed
as differentially expressed in OA vs healthy cartilage. Amongst miRNAs
of interest, we focused on miR-29b as it was overexpressed in IL-1beta
challenged chondrocytes and known to be involved in type I and III
collagen expression in myocytes and ﬁbroblasts. We demonstrated
a 6-fold induction of miR-29b in chondrocytes of osteoarthritic
patients. Reporter gene experiment (luciferase activity) of chimeric
constructs (Luciferase-Type II collagen 3’UTR) in HeLa cells
conﬁrmed the presence of miR-29b seed region. Stable overexpression
of miR-29b in ATDC5 cell line reduced collagen synthesis during
chondrogenic differentiation. Finally,preliminary data suggested that
miR-29 overexpression in human chondrocytes reduced C2CP secre-
tion (25%).
Conclusions: MiRNAs are differentially expressed during loss of chon-
drocytes phenotype and miR-29b is over expressed in osteoarthritic
patients. Using molecular (mutation of seed sequence) and functional
(Sirius red staining and C2CP ELISA) approaches we demonstrated that
miR-29b inhibited type II collagen expression.
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POTENTIAL ROLE OF NUCLEAR ORPHAN RECEPTORS NR4A1 AND
NR4A3 IN HUMAN CHONDROCYTES
H. Angerer 1, D. Krusch 1, A. Deutsch 2, G. Gruber 3, D. Setznagl 1,
M.L. Kremser 1, A. Leithner 3, M.H. Stradner 1, W.B. Graninger 1. 1Dept. of
Rheumatology and Immunology, Med. Univ., Graz, Austria; 2Dept. of
Haematology, Med. Univ., Graz, Austria; 3Dept. of Orthopaedic Surgery,
Med. Univ., Graz, Austria
Purpose: Chondrocyte apoptosis and abundance of matrix-metal-
loproteases (MMPs) and aggrecanases (ADAMTSs) leads to breakdown of
articular cartilage in osteoarthritis (OA). A previous gene expression
proﬁling experiment using chondrocytes treated with the lipid signalling
mediator sphingosine-1-phosphate (S1P) has shown all three members of
the nuclear orphan receptor NR4A subgroup among the top ten deregu-
lated genes. This ﬁnding was conﬁrmed by quantitative real-time PCR.
Nuclear orphan receptors act as ligand-independent transcriptionally
activated regulator proteins; they are known to be involved in prolifera-
tion, apoptosis and gene-regulation in various tissues. We evaluated the
inﬂuence of NR4A3 on chondrocyte gene expression. Furthermore we
investigated the role of NR4A1 by employing the NR4A1 agonist Cyto-
sporone B (CsnB).
Methods: siRNA knock-down of NR4A1 and NR4A3 was performed in
primary human chondrocytes isolated from OA patients who underwent
total knee joint replacement and in the C28I2 chondrocyte cell line.Relative mRNA expression of NR4A1 and NR4A3 receptor, ADAMTS-4 and
-5, MMP13, iNOS and collagen II was determined using quantitative real-
time PCR. NR4A1 expressionwas quantiﬁed in C28I2 cells exposed to CsnB.
Cytotoxicity (MTS assay) and apoptosis (Caspase 3/7 activity) were eval-
uated after 12 and 72 hours, respectively.
Results: NR4A1: CsnB increases NR4A1 gene expression in a concentration
dependent manner. CsnB dependent NR4A1 presence led to increased
caspase-3 and -7 activities in human chondrocytes and C28I2 cell line cells,
respectively.
NR4A3- mRNA was found to be expressed in OA chondrocytes and in the
C28I2 cell line. siRNA knock-down achieved 60% ( 7%) reduction of
NR4A3 mRNA expression. This decrease in NR4A3 expression led to a 45%
( 5%) decline of MMP-13 expression. Furthermore ADAMTS-5 mRNA
expression was reduced 54% ( 22%). Gene expression of ADAMTS-4,
iNOS, and collagen II remained unaltered by diminished NR4A3
expression.
Conclusions: Our results implicate a pro-apoptotic role of NR4A1 in
human chondrocytes. Furthermore, NR4A3 is involved in the regulation of
MMP-13 and ADAMTS-5 expression. NR4A1 and NR4A3 nuclear receptors
might be of relevance for future osteoarthritis therapies.
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STIMULATION OF SUPERFICIAL ZONE PROTEIN/LUBRICIN
ACCUMULATION BY HEDGEHOG SIGNALING IN SURFACE ZONE
ARTICULAR CHONDROCYTE
T. Iwakura, A. Inui, A.H. Reddi. Univ. of California, Davis, Sacramento, CA,
USA
Purpose: Superﬁcial zone protein (SZP), homologous to lubricin, is
a large proteoglycan that is synthesized and secreted into synovial ﬂuid
by surface zone articular chondrocytes (SZAC) and synovial cells. SZP is
known to function as a boundary lubricant of articular cartilage and
plays an important role in cartilage homeostasis and degeneration. It is
well established that cytokines play important roles in cartilage
homeostasis. We have previously reported that TGF-b is a critical
regulator of SZP synthesis and accumulation in SZAC. In addition,
hedgehog signaling also plays a key role in skeletal development,
including synovial joint induction, and has been implicated in cartilage
homeostasis and the pathogenesis of osteoarthritis. However, the action
of hedgehog signaling on SZAC is unknown. We hypothesized that
hedgehog signaling regulates SZP synthesis and accumulation in SZAC.
The aim of this study was to investigate the action of hedgehog
signaling on SZP accumulation. We also examined interactions between
hedgehog signaling and TGF-b1.
Methods: Surface zone articular cartilage was harvested from the femoral
condyles of stiﬂe joints from 3-month-old calves and digested with 0.2%
collagenase P. Isolated chondrocytes were cultured in monolayer at
a density of 1105 cells/well in 12-well plates in DMEM/F12 with 10% FBS.
After 24-hours equilibration, cells were switched to serum-free DMEM/F12
with ITS+ Premix containing various concentrations of Sonic hedgehog
(Shh), Indian hedgehog (Ihh), hedgehog signaling inhibitor cyclopamine,
and TGF-b1 (n¼6, for all experiments). The medium from the cultures was
harvested after the 4-day treatment and quantitatively analyzed for SZP
protein by enzyme-linked immunosorbent assay (ELISA) using monoclonal
antibody S6.79.
Results: Both Shh and Ihh stimulated SZP accumulation signiﬁcantly
(p<0.01) at all concentration (0.1, 0.3 and 1 mg/ml). Compared to control, 1
mg/ml Shh treatment elicited a maximum increase of 2.4-fold while 1 mg/
ml Ihh produced a 1.7-fold increase (Figure 1). The up-regulation of SZP
accumulation by 1 mg/ml Shh was reduced in part by 1 mM cyclopamine
and completely abolished at a dose of 10 mM (Figure 2). In addition, there
were additive effects between Shh (1 mg/ml) or Ihh (1 mg/ml) and TGF-b1
(1, 3 and 10 ng/ml) (Figure 3).
Conclusions: The present study showed for the ﬁrst time the action of
hedgehog signaling on SZAC. Our results demonstrate that activation of
hedgehog signaling by Shh and Ihh stimulates SZP accumulation. These
results might provide insights into understanding normal articular
joint homeostasis and the progression of cartilage degeneration, and
aid in the potential utility of hedgehog signaling in cartilage
regeneration.
